Search company, investor...

Yino

szyino.com

Founded Year

2004

Stage

Incubator/Accelerator | Alive

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+10 points in the past 30 days

About Yino

Yino is an information technology enterprise engaged in product development, production, and sales in the field of medical oncology.

Headquarters Location

Nanshan Science and Technology Park 10th Floor, Unit B, Building G4

Shenzhen, Guangdong,

China

0755-83185778

Missing: Yino's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Yino's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Yino

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Yino is included in 1 Expert Collection, including Digital Health.

D

Digital Health

13,069 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Latest Yino News

Hypercoagulable Treatment Market Opportunities, Analysis of Features, Benefits And Applications By 2028 | Key Players Are Yino Pharma Limited, Sanofi , Teva Pharmaceutical Industries Ltd

Dec 21, 2021

| Key Players Are Yino Pharma Limited, Sanofi , Teva Pharmaceutical Industries Ltd This Hypercoagulable Treatment Market report takes into consideration diverse segments of the market analysis that today’s business ask for. The report provides estimations of CAGR values, market drivers and market restraints about the industry which are helpful for the businesses in deciding upon numerous strategies. The base year for calculation in the report is taken as 2017 whereas the historic year is 2016 which will tell you how Hypercoagulable Treatment Market is going to perform in the forecast years by informing you what the market definition, classifications, applications, and engagements are. The report helps you to be there on the right track by making you focus on the data and realities of the industry. The research studies of this Hypercoagulable Treatment Market report helps to evaluate several important parameters that can be mentioned as investment in a rising market, success of a new product, and expansion of market share. Market estimations along with the statistical nuances included in this market report give an insightful view of the market. The market analysis serves present as well as future aspects of the market primarily depending upon factors on which the companies contribute in the market growth, crucial trends and segmentation analysis. This Hypercoagulable Treatment Market research report also gives widespread study about different market segments and regions. The hypercoagulable treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to growing at a CAGR of 3.98% in the above-mentioned forecast period. Increasing prevalence of hypercoagulable disease will drive the growth of the market. Get Sample Report + All Related Graphs & Charts (with COVID 19 Analysis) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hypercoagulable-treatment-market Major Players:- Yino Pharma Limited, Sanofi , Teva Pharmaceutical Industries Ltd., Shenzhen Techdow Pharmaceutical Co., Ltd, Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shanghai Fosun Pharmaceutical (Group) Co., Ltd, Novartis AG, Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., Hikma Pharmaceuticals PLC, Hebei Changshan Biochemical Pharmaceutical Co. Ltd., Fresenius Kabi AG, Eisai Co., Ltd., Aspen Holdings, Mylan N.V., F. Hoffmann-La Roche Ltd. and Pfizer Inc. among other domestic and global players. Competitive Landscape and Hypercoagulable Treatment Market Share Analysis Hypercoagulable treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to hypercoagulable treatment market. Elevating financial investment on research and development activities for hypercoagulable treatment will boost the hypercoagulable treatment market in the forecast period of 2021-2028. Additionally, increasing pace of early diagnosis of hypercoagulable disease in developed as well as developing anticipated to accelerate the future growth pace of the global hypercoagulable treatment market. On the contrary, increasing advanced treatment options and growing number of product launches will heighten numerous opportunities that will commence to the germination of the hypercoagulable treatment market in the above-mentioned forecast period. Stringent regulatory processes and lack of accessibility will act as restraints for the growth of hypercoagulable treatment market. This hypercoagulable treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT– GET FREE COVID-19 SAMPLE@ https://www.databridgemarketresearch.com/covid-19-impact/global-hypercoagulable-treatment-market Global Hypercoagulable Treatment Market Scope and Market Size Hypercoagulable treatment market is segmented on the basis of type, drugs, route of administration, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. Hypercoagulable treatment market has also been segmented based on the type into factor V Leiden, prothrombin 20210, antiphospholipid syndrome and others. Hypercoagulable treatment market has also been segmented based on the drugs into heparin, warfarin, vitamin K antagonist, direct thrombin inhibitors and others. Hypercoagulable treatment market has also been segmented based on the route of administration into oral and injectable. Hypercoagulable treatment market has also been segmented based on the end user into hospitals, homecare, speciality centres, and others. Hypercoagulable treatment market has also been segmented based on the distribution channel into hospital pharmacy, online pharmacy, retail pharmacy and others. Table of Contents-Snapshot Chapter 13 Methodology and Data Source For More Insights Get FREE Detailed TOC @ Hypercoagulable Treatment Market Country Level Analysis Hypercoagulable treatment market is analysed and market size insights and trends are provided by country, type, drugs, route of administration, end user and distribution channel as referenced above. The countries covered in the hypercoagulable treatment market report are the U.S., Canada and Mexico in North America,  Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. North America accounts for the largest market share in the hypercoagulable treatment market due to the presence of major market players and enormous expenditure on healthcare sector. Europe region is followed by North America due to the existence of advanced healthcare infrastructure. Furthermore, Asia Pacific is anticipated to carry the most leading germination pace in the estimated duration of 2021 to 2028 due to increased local presence of the key market players and growing demand of hypercoagulable treatment products in the region. The country section of the hypercoagulable treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. Healthcare Infrastructure growth Installed base and New Technology Penetration Hypercoagulable treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hypercoagulable Treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hypercoagulable Treatment market. The data is available for historic period 2010 to 2019. About Data Bridge Market Research:   An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Yino Frequently Asked Questions (FAQ)

  • When was Yino founded?

    Yino was founded in 2004.

  • Where is Yino's headquarters?

    Yino's headquarters is located at Nanshan Science and Technology Park, Shenzhen.

  • What is Yino's latest funding round?

    Yino's latest funding round is Incubator/Accelerator.

  • Who are the investors of Yino?

    Investors of Yino include Baidu AI Accelerator.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.